JAK2

RBC: JAK2 · Substrate: pEY ·

MeasuredDerived

Mutation	Cancer type	Organ	Source
`V617F`	haematopoietic_neoplasm_haematopoietic_and_lymphoid_tissue	Blood/Lymphatic System	https://doi.org/10.1093/nar/gkaa945
`V617F`	other_haematopoietic_and_lymphoid_tissue	Blood/Lymphatic System	https://doi.org/10.1093/nar/gkaa945
`V617F`	malignant_melanoma_NS	Skin	https://doi.org/10.1093/nar/gkaa945
`V617F`	carcinoma_lung	Lung	https://doi.org/10.1093/nar/gkaa945
`V617F`	lymphoid_neoplasm_haematopoietic_and_lymphoid_tissue	Blood/Lymphatic System	https://doi.org/10.1093/nar/gkaa945
`V617F`	carcinoma_liver	Liver	https://doi.org/10.1093/nar/gkaa945
`V617F`	carcinoma_thyroid	Thyroid	https://doi.org/10.1093/nar/gkaa945
`V617F`	glioma_central_nervous_system	Brain/CNS	https://doi.org/10.1093/nar/gkaa945
`V617F`	carcinoma_ovary	Ovary	https://doi.org/10.1093/nar/gkaa945
`V617F`	AML-US	Blood/Lymphatic System	https://doi.org/10.1093/nar/gkaa945
`V617F`	LAML-CN	Blood/Lymphatic System	https://doi.org/10.1093/nar/gkaa945
`V617F`	LAML-KR	Blood/Lymphatic System	https://doi.org/10.1093/nar/gkaa945
`V617F`	LIHC-US	Liver	https://doi.org/10.1093/nar/gkaa945
`V617F`	LAML	Blood/Lymphatic System	https://doi.org/10.1093/nar/gkaa945